Changes of serum homocysteine level of renal transplant recipients

Kong Xiangrui; Xiao Li; Liu Zhijia; Gao Yu; Bi Lili; Shi Bingyi

doi:10.3969/j.issn.1674-7445.2015.03.009

Volume 6 Issue 3

May 2015

Turn off MathJax

Article Contents

Article Navigation > ORGAN TRANSPLANTATION > 2015 > 6(3): 174-178

Kong Xiangrui, Xiao Li, Liu Zhijia, et al. Changes of serum homocysteine level of renal transplant recipients[J]. ORGAN TRANSPLANTATION, 2015, 6(3): 174-178. doi: 10.3969/j.issn.1674-7445.2015.03.009

Citation:

Kong Xiangrui, Xiao Li, Liu Zhijia, et al. Changes of serum homocysteine level of renal transplant recipients[J]. ORGAN TRANSPLANTATION, 2015, 6(3): 174-178. doi: 10.3969/j.issn.1674-7445.2015.03.009

Citation:

Kong Xiangrui, Xiao Li, Liu Zhijia, et al. Changes of serum homocysteine level of renal transplant recipients[J]. ORGAN TRANSPLANTATION, 2015, 6(3): 174-178. doi: 10.3969/j.issn.1674-7445.2015.03.009

PDF( 228 KB)

Changes of serum homocysteine level of renal transplant recipients

doi: 10.3969/j.issn.1674-7445.2015.03.009

Military Academy of Medical Science, Beijing 100091, China

More Information

Corresponding author: Shi Bingyi, Email:shibingyi@medmail.com.cn
Received Date: 2015-03-06
Available Online: 2021-01-19
Publish Date: 2015-05-15

Abstract

Abstract

Objective To observe the changes of serum homocysteine (Hcy) level of renal transplant recipients before and after renal transplantation, and assess the correlation between serum Hcy level and graft function. Methods Thirty-three recipients were included into the transplantation group, who underwent renal allograft transplantation in the Organ Transplant Institute of the 309^th Hospital of People's Liberation Army and had renal function recovered stably from January 2013 to June 2014. And 65 patients who were confirmed as chronic renal failure (CRF) by clinical examinations were included into the CRF group and 30 healthy people were included into the control group. A retrospective cross-sectional study was conducted on all of these subjects. Serum Hcy, serum creatinine (Scr) and blood urea nitrogen (BUN) levels of these three groups were compared. Serum Hcy and Scr levels of the transplantation group were continuously monitored before transplantation and at 3, 7, 14 and 21d after transplantation. The correlation between the changes of serum Hcy levels and the renal function before and after transplantation was assessed. Results Serum Hcy level of the CRF group was (25±10) μmol/L, which was significantly higher than (9±4) μmol/L of the control group and (15±9) μmol/L of the transplantation group in stable period, with statistical significance (all in P < 0.001). Serum Hcy level of the transplantation group was significantly higher than that of the control group(P < 0.001). Scr level of the CRF group, the transplantation group and the control group was(708±302)μmol/L, (98±23) μmol/L and (72±18) μmol/L, respectively. Scr level of the CRF group was significantly higher than those of the transplantation group and the control group (all in P < 0.001). BUN level of the CRF group, the transplantation group and the control group was (18.1±5.9) mmol/L, (10.9±5.3) mmol/L and (4.9±1.3) mmol/L, respectively. BUN level of the CRF group was significantly higher than that of the transplantation group and the control group (all in P < 0.001), and BUN level of the transplantation group was significantly higher than that of the control group (P < 0.001). With the improvement in renal function after transplantation, Scr and serum Hcy levels of the transplantation group deceased gradually. At 14 d after transplantation, Hcy level decreased to the minimum of (15±5) μmol/L. Compared with (25±10) μmol/L before transplantation, the difference had statistical significance (P < 0.05). Within 14 d after transplantation, serum Hcy level of the transplantation group was positively correlated with Scr level (r=0.761, P < 0.05). Conclusions Serum Hcy level of the renal transplant recipients is correlated with the graft function. The combined detection of serum Hcy and renal function index has certain guiding significance in the prevention of hyperhomocysteinemia and the early assessment of graft function.
- Renal transplantation,
- Homocysteine,
- Serum creatinine,
- Blood urea nitrogen

FullText(HTML)

References(18)

References

[1]	Watorek E, Szymczak M, Boratynska M, et al. Cardiovascular risk in kidney transplant recipients receiving mammalian target of rapamycin inhibitors[J]. Transplant Proc, 2011, 43(8):2967-2969. doi: 10.1016/j.transproceed.2011.08.009
[2]	Weir MR, Burgess ED, Cooper JE, et al. Assessment and management of hypertension in transplant patients[J]. J Am Soc Nephrol, 2015. https://www.ncbi.nlm.nih.gov/pubmed/25653099/
[3]	McCaughan JA, Courtney AE. The clinical course of kidney transplant recipients after 20 years of graft function[J]. Am J Transplant, 2015, 15(3):734-740. doi: 10.1111/ajt.13041
[4]	Janda K, Aksamit D, Drozdz M, et al. Influence of elevated homocystein level and selected lipid parameters in kidney transplant patients on the progression of atherosclerotic changes assessed by intima-media thickness index (CCA-IMT)[J]. Przegl Lek(波兰文), 2012, 69(9):670-674. http://europepmc.org/abstract/med/23401987
[5]	陈玉映, 郑素琳, 陈盈文, 等.降同型半胱氨酸疗法对经皮冠状动脉介入治疗术后患者不良心血管事件的影响[J].实用医学杂志, 2013, 29(5):769-771. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201305037.htm Chen YY, Zheng SL, Chen YW, et al. Effect of lower homocysteine therapy on adverse cardiovascular events of postoperative patients with percutaneous coronary intervention[J]. J Pract Med, 2013, 29(5):769-771. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201305037.htm
[6]	Tan H, Shi C, Jiang X, et al. Hyperhomocysteinemia promotes vascular remodeling in vein graph in mice[J]. Front Biosci, 2014, 19:958-966. doi: 10.2741/4260
[7]	张彦, 杨永长, 王伟, 等.血清同型半胱氨酸与肾脏疾病的关系[J].西部医学, 2010, 22(8):1527-1528. http://www.cnki.com.cn/Article/CJFDTOTAL-XIBU201008075.htm Zhang Y, Yang YC, Wang W, et al. Relationship of serum homocysteine and nephronia[J]. Med J West China, 2010, 22(8):1527-1528. http://www.cnki.com.cn/Article/CJFDTOTAL-XIBU201008075.htm
[8]	Welch GN, Loscalzo J. Homocysteine and atherothrombosis[J]. N Engl J Med, 1998, 338(15):1042-1050. doi: 10.1056/NEJM199804093381507
[9]	Marcucci R, Zanazzi M, Bertoni E, et al. Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients[J]. Transplantation, 2003, 75(9):1551-1555. doi: 10.1097/01.TP.0000058810.59825.58
[10]	Ueland PM, Refsum H, Stabler SP, et al. Total homocysteine in plasma or serum:methods and clinical applications[J]. Clin Chem, 1993, 39(9):1764-1779. https://www.ncbi.nlm.nih.gov/pubmed/8375046
[11]	Ducloux D, Motte G, Challier B, et al. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients:a prospective study[J]. J Am Soc Nephrol, 2000, 11(1):134-137. http://d.scholar.cnki.net/detail/SJPD0006_U/SJPD12090303961431
[12]	Wilson PW. Homocysteine and coronary heart disease:how great is the hazard?[J]. JAMA, 2002, 288(16):2042-2043. doi: 10.1001/jama.288.16.2042
[13]	Bostom AG, Lathrop L. Hyperhomocysteinemia in end-stage renal disease:prevalence, etiology, and potential relationship to arteriosclerotic outcomes[J]. Kidney Int, 1997, 52(1):10-20. doi: 10.1038/ki.1997.298
[14]	Nygård O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease[J]. N Engl J Med, 1997, 337(4):230-236. doi: 10.1056/NEJM199707243370403
[15]	林联韵, 高丽丹, 吴莉春, 等.慢性肾衰竭患者血清HCY水平与其CysC、CREA的关系[J].北方药学, 2013, (3):63-64. http://www.cnki.com.cn/Article/CJFDTOTAL-BFYX201303061.htm Lin LY, Gao LD, Wu LC, et al. Relationship between serum homocysteine and cystain C, creatinine in chronic renal failure patients[J]. J North Pharm, 2013, (3):63-64. http://www.cnki.com.cn/Article/CJFDTOTAL-BFYX201303061.htm
[16]	范连慧, 刘龙, 吴晓倩, 等.肾移植前后血浆同型半胱氨酸浓度升高与心血管病变相关[J].中华器官移植杂志, 2006, 27(8):506-507. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHQG200608020.htm Fan LH, Liu L, Wu XQ, et al. Elevated plasma homocysteine concentration associated with cardiovascular disease before and after renal transplantation[J]. Chin J Organ Transplant, 2006, 27(8):506-507. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHQG200608020.htm
[17]	Caldera A, Dec GW. Hyperhomocysteinemia and transplant coronary artery disease[J]. Transplantation, 2002, 74(10):1359-1364. doi: 10.1097/00007890-200211270-00001
[18]	Mohammadi A, Omrani L, Omrani LR, et al. Protective effect of folic acid on cyclosporine-induced bone loss in rats[J]. Transpl Int, 2012, 25(1):127-133. doi: 10.1111/tri.2011.25.issue-1

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(2)

Get Citation

PDF

XML

Article Metrics

Article views (105) PDF downloads(4)

Changes of serum homocysteine level of renal transplant recipients

doi: 10.3969/j.issn.1674-7445.2015.03.009

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Changes of serum homocysteine level of renal transplant recipients

doi: 10.3969/j.issn.1674-7445.2015.03.009

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content